AN
55
-2
NRG
40
3
UA
56
3
HAL
41
2
AMG
58
8
ABT
53
-3
GIS
34
-3
PNW
59
-4
DAL
64
2
MOS
50
4
RF
48
-3
AVGO
47
12
SEE
48
-5
HBAN
56
2
DNB
58
-2
HBI
52
4
EMC
77
6
UPS
51
-4
LEG
36
5
INTU
62
5
AN
55
-2
NRG
40
3
UA
56
3
HAL
41
2
AMG
58
8
ABT
53
-3
GIS
34
-3
PNW
59
-4
DAL
64
2
MOS
50
4
RF
48
-3
AVGO
47
12
SEE
48
-5
HBAN
56
2
DNB
58
-2
HBI
52
4
EMC
77
6
UPS
51
-4
LEG
36
5
INTU
62
5
Financhill
Back

RBC U.S. Discount Bond ETF USD Vs. Aligos Therapeutics Industry Stock Comparison

Sell
36

RUDB.U.TO
RBC U.S. Discount Bond ETF USD

Last Price:
15.34
Seasonality Move:
1.48%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
34.48
Seasonality Move:
10.65%
Sell
36
RBC U.S. Discount Bond ETF USD (RUDB.U.TO) is a Sell

Is RBC U.S. Discount Bond ETF USD a Buy, Sell or Hold?

  • The current RBC U.S. Discount Bond ETF USD [RUDB.U.TO] share price is $15.34. The Score for RUDB.U.TO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • RUDB.U.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RUDB.U.TO Stock Price Chart

What is RBC U.S. Discount Bond ETF USD's stock price today?

  • The RBC U.S. Discount Bond ETF USD share price today is $15.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RUDB.U.TO is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RUDB.U.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 54.84 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.26 - 15.34) Buy
Bollinger Bands (100): (15.24 - 15.44) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

RUDB.U.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.34 Buy
20-day SMA: 15.3 Buy
50-day SMA: 15.34 Buy
200-day SMA: 15.16 Buy
8-day EMA: 15.33 Buy
20-day EMA: 15.32 Buy
50-day EMA: 15.33 Buy
200-day EMA: 15.18 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

RBC U.S. Discount Bond ETF USD Earnings Growth & RUDB.U.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

RBC U.S. Discount Bond ETF USD Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):